Enrico N De Toni

Enrico N De Toni

Ludwig Maximilians Universität München - Munich / Germany
Medical and Health Sciences / Internal Medicine
AD Scientific Index ID: 1761959
Ludwig Maximilian University of Munich
person_outline Enrico N De Toni's MOST POPULAR ARTICLES
1-) The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects Signal transduction and targeted therapy 5 (1), 87, 2020
2-) Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma … Journal of Clinical Oncology 40 (4_suppl), 379-379, 2022
3-) Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma Journal of hepatology 71 (6), 1164-1174, 2019
4-) The role of the novel Th17 cytokine IL-26 in intestinal inflammation Gut 58 (9), 1207-1217, 2009
5-) The role of the novel Th17 cytokine IL-26 in intestinal inflammationJ Dambacher, F Beigel, K Zitzmann, EN De Toni, B Göke, HM Diepolder, ...Gut 58 (9), 1207-1217, 20093182009